Gitalee Sarker

Gitalee Sarker

Auto-generated profile, based on publicly available information

Gitalee Sarker

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2025 in Nature Communications
Verified
Journal Article
Open access
ALAina Lluch
Aina Lluch
JLJèssica Latorre
Jèssica Latorre
IEISABEL ESPADAS
ISABEL ESPADAS
NONúria Oliveras-Cañellas
Núria Oliveras-Cañellas
José María Moreno-NavarreteJosé María Moreno-Navarrete
José María Moreno-Navarrete
FOFrancisco Jose Ortega
Francisco Jose Ortega
Olfactomedin-2 (OLFM2) is a pleiotropic glycoprotein emerging as a regulator of energy homeostasis. We here show the expression of OLFM2 to be adipocyte-specific and inversely associated with obesity. OLFM2 levels increase during adipogenesis and are suppressed in inflamed adipocytes. Functionally, OLFM2 deficiency impairs adipocyte differentiation, while its over-production enhances the adipogenic transformation of fat cell progenitors. Loss and gain of function experiments revealed that OLFM2 modulates key metabolic and structural pathways, including PPAR signaling, citrate cycle, fatty acid degradation, axon guidance and focal adhesion in 3T3 cell lines and primary human adipocytes. On the molecular level, OLFM2 deficiency in differentiated adipocytes predominantly downregulates genes involved in cell cycle. Extending these findings in vivo, both whole-body Olfm2 knockout and adipose-specific Olfm2 depletion in mice resulted in impaired adipose cell cycle gene expression, with the latter also displaying fat mass accretion and metabolic dysfunction. Collectively, our results underscore a critical role for OLFM2 in adipocyte biology, and support a causative link between reduced adipose OLFM2 and the pathophysiology of obesity.

13 July 2026 in Nature Metabolism
Verified
Journal Article
Open access
GSGitalee Sarker
Gitalee Sarker
EHEmma Haberman
Emma Haberman
ACAnandhakumar Chandran
Anandhakumar Chandran
TMThomas Monfeuga
Thomas Monfeuga
CMCyrielle Maroteau
Cyrielle Maroteau
ADAna I. Domingos
Ana I. Domingos
The regulatory mechanism of leptin’s afferent action in the brain is contingent upon the efferent sympathetic innervation of white and brown adipose tissues. Nonetheless, the peripheral regulation governing the afferent–efferent balance remains ambiguous. Here we show the enriched expression of both leptin receptor ( Lepr ) and β 2 -adrenergic receptor ( Adrb2 ) in perineurial cells that form a barrier around sympathetic ganglia and nerve bundles in adipose tissues, using single-cell RNA sequencing on mouse sympathetic ganglia. Lepr + sympathetic perineurial cells (SPCs) are molecularly similar to endothelial cells. Conditional knockout of Adrb2 in Lepr + cells, including SPCs, predisposes male mice to obesity by lowering energy expenditure and thermogenesis without affecting food intake. Notably, obesity-associated hyperleptinaemia causes apoptosis in SPCs, disrupting the perineurial barrier and concomitant adipose sympathetic neuropathy. This deleterious effect can be reversed by partial reduction of leptin or sympathomimetic β 2 -adrenergic receptor agonism. Clinically, we observed a male-specific synergistic effect of LEPR and ADRB2 polymorphisms on increased body mass index risk in a large European population. We propose that SPCs coordinate the afferent and efferent arms of the neuroendocrine loop of leptin action to regulate energy expenditure and body weight.

8 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GSGitalee Sarker
Gitalee Sarker
EHEmma Habermann
Emma Habermann
ACAnandhakumar Chandran
Anandhakumar Chandran
TMThomas Monfeuga
Thomas Monfeuga
CMCyrielle Maroteau
Cyrielle Maroteau
ADAna Domingos
Ana Domingos
The regulatory mechanism of leptin’s afferent action in the brain, constituting a negative feedback loop, is contingent upon the efferent sympathetic innervation of white and brown adipose tissues. Nonetheless, the peripheral regulation governing the relative strengths of the afferent and efferent arms remains ambiguous. Using single-cell RNA sequencing on murine sympathetic ganglia, we identified the unique expression of both the leptin receptor (LepR) and the beta 2 adrenergic receptor (Adrb2) in perineurial cells that form a barrier around sympathetic ganglia and nerve bundles in adipose tissues. We show that LepR + Sympathetic Perineurial Cells (SPCs) are molecularly similar to endothelial cells and that conditional knockout of Adrb2 in LepR + SPCs predisposes mice to obesity without affecting food intake. Notably, we found that hyperleptinemia associated with obesity causes apoptosis in SPCs, leading to a significant erosion of the perineurial barrier and concomitant adipose sympathetic neuropathy. We further show that this deleterious effect can be reversed by sympathomimetic beta 2 adrenergic receptor agonism. These results have relevance to human obesity, as we observed a synergistic effect of highly common polymorphisms of LEPR and ADRB2 on the risk of increased BMI in a large European population. We propose that SPCs are the nexus of leptin action by integrating the afferent and efferent arms of the neuroendocrine loop to influence its setpoint.

6 November 2026 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
GSGitalee Sarker
Gitalee Sarker
ADAna I. Domingos
Ana I. Domingos

11 August 2026 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
GSGitalee Sarker
Gitalee Sarker
EHEmma Haberman
Emma Haberman
ACAnandhakumar Chandran
Anandhakumar Chandran
TMThomas Monfeuga
Thomas Monfeuga
CMCyrielle Maroteau
Cyrielle Maroteau
ADAna I. Domingos
Ana I. Domingos